本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Avidity Biosciences, Inc.

50.36
+1.893.90%
盤後50.07-0.2925-0.58%17:22 EDT
成交量:735.85萬
成交額:3.69億
市值:64.79億
市盈率:-14.12
高:51.40
開:49.07
低:48.37
收:48.47
52周最高:56.00
52周最低:21.51
股本:1.29億
流通股本:9,981.53萬
量比:3.29
換手率:7.37%
股息:- -
股息率:- -
每股收益(TTM):-3.5671
每股收益(LYR):-2.8885
淨資產收益率:-37.76%
總資產收益率:-24.01%
市淨率:5.43
市盈率(LYR):-17.43

資料載入中...

2024/03/01

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/29

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/28

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/24

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/05

重要事件披露

Form 8-K - Current report
2023/12/14

重要事件披露

Form 8-K - Current report
2023/12/13

重要事件披露

Form 8-K - Current report
2023/12/05

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/28

重要事件披露

Form 8-K - Current report
2023/11/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/10/10

重要事件披露

Form 8-K - Current report
2023/08/08

重要事件披露

Form 8-K - Current report
2023/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/10

重要事件披露

Form 8-K - Current report